目的:探讨火龙罐辅助治疗心肺气虚、血瘀饮停慢性心力衰竭(chronic heart failure，CHF)患者的效果。方法:选择2022 年 2 月—2023 年 8 月厦门市中医院心血管科确诊的 120 例心肺气虚、血瘀饮停CHF患者作为研究对象，按照随机数表法将患者分为两组，每组 60 例。对照组接受常规西医治疗，观察组在此基础实施火龙罐辅助治疗，比较两组治疗前后心功能分级、中医症候积分、明尼苏达心力衰竭生活质量问卷(Minnesota living heart failure questionnaire，MLHFQ)评分、N末端B型脑钠尿肽前体(N terminal pro B type natriuretic peptide，NT-proBNP)水平、临床效果及随访 6 个月再住院情况。结果:观察组治疗后心功能分级低于对照组，差异有统计学意义(P＜0。05);观察组治疗后中医症候积分、MLHFQ评分、NT-proBNP水平低于对照组，且观察组治疗前后中医症候积分、MLHFQ评分、NT-proBNP差值大于对照组，差异有统计学意义(P＜0。05);观察组临床效果优于对照组，差异有统计学意义(P＜0。05);两组随访 6 个月再住院率比较，差异无统计学意义(P＞0。05)。结论:火龙罐辅助治疗有助于改善心肺气虚、血瘀饮停CHF患者心功能分级、中医症候积分，提升生活质量，降低NT-proBNP水平，提高临床效果。
Effect of Huolong Pot in the Adjuvant Treatment of Patients with Heart and Lung Qi Deficiency,Blood Stasis and Fluid Stasis Chronic Heart Failure
Objective:To investigate the effect of Huolong pot in the adjuvant treatment of patients with heart and lung Qi deficiency,blood stasis and fluid stasis chronic heart failure(CHF).Method:A total of 120 patients with heart and lung Qi deficiency,blood stasis and fluid stasis CHF who diagnosed in the Department of Cardiology of Xiamen Hospital of Traditional Chinese medicine were selected as the study objects,and the patients were divided into two groups according to the random number table method,60 cases in each group.The control group was given conventional western medicine treatment,and the observation group was given Huolong pot adjuvant treatment on the basis of this treatment.The cardiac function grade,traditional Chinese medicine syndrome score,Minnesota living heart failure questionnaire(MLHFQ)score,N terminal pro B type natriuretic peptide(NT-proBNP)level before and after treatment,clinical effect and rehospitalization after 6 months of follow-up were compared between two groups.Result:The cardiac function grade of the observation group after treatment was lower than that of the control group,and the difference was statistically significant(P＜0.05);after treatment,the traditional Chinese medicine symptom score,MLHFQ score and NT-proBNP level in the observation group were lower than those in control group,and the differences of traditional Chinese medicine symptom score,MLHFQ score and NT-proBNP before and after treatment in the observation group were greater than those in the control group,the differences were statistically significant(P＜0.05);the clinical effect of the observation group was better than that of the control group,and the difference was statistically significant(P＜0.05);there was no statistically significant difference in the readmission rate between the two groups after a 6 month of follow-up(P＞0.05).Conclusion:Huolong pot in the adjuvant treatment of patients with heart and lung Qi deficiency,blood stasis and fluid stasis CHF is helpful to improve the cardiac function classification and traditional Chinese medicine syndrome score,improve the quality of life,reduce the level of NT-proBNP,and improve the clinical effect.
Huolong potHeart and lung Qi deficiencyBlood stasis and fluid stasisChronic heart failure
万方数据
维普
